Search results for "rigaku"
Selected Filters:
MaxCyte signs platform license agreement with Adicet Bio
MaxCyte’s Flow Electroporation technology and ExPERT platform to support the development of Adicet’s gamma delta T cell therapy gene edited programs
TARGATT large knock-in technology
Addressing the analytical gaps in modern therapeutic development
How to tackle PFAS in the shifting regulatory landscape
PFAS analysis without compromise
Hypertension as a driver of cardiovascular and renal disease
Fast, slide-free cell counting with CellDrop
AliveDx’s MosaiQ gains FDA Class II 510(k) exempt device status
The MosaiQ instrument is a next-generation, continuous random-access immunoassay platform offering labs automation, simple workflows, fast, multiplexed results and actionable insights for complex-to-diagnose conditions
How to Buy Analytical Technology for Cell Line Development
As cell line development (CLD) programs grow in complexity and scale, with increasing demands for speed, data quality, and adaptability, it is essential to choose the right analytical tools that will future-proof your workflow.
Trailblazing earlier diagnosis of multiple myeloma for better patient outcomes
Guest editorial by Dale Powner, Country Manager for the UK, Ireland and Nordics at Binding Site, part of Thermo Fisher Scientific
How advocacy shaped the regulation of laboratory-developed tests
Laboratory leaders are turning to rapid AST to advance antimicrobial stewardship
With antimicrobial resistance on the rise, rapid AST offers a lifeline for critically ill patients and supports improved antibiotic stewardship